维普期刊资源整合服务平台（V6.5）

84篇 您的检索式：作者名="SAROSDY"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	MAINTENANCE BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR RECURRENT TA, T1 AND CARCINOMA IN SITU TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A RANDOMIZED SOUTHWEST ONCOLOGY GROUP STUDY显示文摘	DONALD L. LAMM BRENT A. BLUMENSTEIN JOHN D. CRISSMAN JAMES E. MONTIE JAMES E. GOTTESMAN BRUCE A. LOWE MICHAEL F. SAROSDY ROBERT D. BOHL H. BARTON GROSSMAN THOMAS M. BECK JOSEPH T. LEIMERT E. DAVID CRAWFORD	2000	The Journal of Urology2000，，4：	2
2	Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer显示文摘	Messing EM Manola J Sarosdy M	1999	N Engl J Med1999，341，24：	1
3	Improved detection of recurrent bladder can-cer using the Bard BTA stat Test显示文摘	Sarosdy MF Hudson MA Ellis WJ	1997	Urology1997，50，3：	1
4	Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer显示文摘	Sarosdy MF Schellhammer P Bokinsky G	2002	J Urol2002，168，5：	1
5	Comparison of guserelin and Leuprolide in Combined androgen blockage therapy显示文摘	Sarosdy MF Schellhammer PF Sharifi R	1998	Urology1998，52，1：	1
6	Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer 显示文摘	Sarosdy MF Schellhammer P Bokinsky G	2002	J Urol2002，168，5：	1
7	Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node positive prostate cancer显示文摘	Messing EM Manola J Sarosdy M	1999	N Engl J Med1999，341，24：	1
8	Results of a multicenter trial using the BTA-test to monitor for and diagnose recurrent bladder cancer显示文摘	Sarosdy MF De-Vere-White RW Soloway MS	1995	J Urol1995，154，2：	1
9	Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer 显示文摘	Sarosdy MF White RW Soloway MS	1995	J Urol1995，154，21：	1
10	Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria 显示文摘	Sarosdy MF Kahn PR Ziffer MD	2006	J Urol2006，176，1：	1
11	Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer 显示文摘	Sarosdy MF Schellhammer P Bokinsky G	2002	J Urol2002，168，5：	1
12	Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer显示文摘	Sarosdy MF Schellhammer P Bokinsky G	2002	J Urol2002，168，5：	1
13	Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria显示文摘	Sarosdy MF Kahn PR Ziffer MD	2006	J Urol2006，176，1：	1
14	Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria显示文摘	Sarosdy MF Kahn PR Ziffer MD	2006	J Urol2006，176，1：	1
15	Immediate hormonal therapy compared with observation after radical proetatectomy and prairie lymphadenectomy in men with node positive prostate eancer显示文摘	Messing EM Manola J Sarosdy M	1999	N Engl J Med1999，341，24：	1
16	Significant long-term patient benefit with BCG maintenance therapy-a Southwest Oncology Group Study显示文摘	Lamm DL Blumenstein B Sarosdy M	1997	J Urol1997，157，：	1
17	Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer 显示文摘	Messing ME Manola J Sarosdy M	1999	N Engl J Med1999，341，24：	1
18	Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer显示文摘	Sarosdy M F Schellhammer P Bokinsky G	2002	J Urol2002，168，5：	1
19	Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer显示文摘	Michael F Sarosdy MF ScheUhammer P	2002	J Urol2002，168，5：	1
20	Use of a Multi larger Fluorescence In Situ Hybridization Assay to Diagnose Bladder Cancer in Patients With Hematuria 显示文摘	Sarosdy M F Kahn P R Ziffer M D	2006	J Urol2006，176，1：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示